Skip to content

Desflurane Versus Propofol Anesthesia for Off-Pump CABG

Comparison of Desflurane and Propofol Anesthesia for Off-Pump Coronary Artery Bypass Grafting Surgery

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00528515
Enrollment
80
Registered
2007-09-12
Start date
2007-02-28
Completion date
2008-03-31
Last updated
2008-05-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronary Artery Disease

Keywords

anesthesia intravenous, propofol, anesthesia inhalation, desflurane, heart surgery, coronary artery by-pass off-pump, hemodynamic processes, anesthesia

Brief summary

The purpose of this study is to prove if anesthesia maintained with the inhaled volatile anesthetic desflurane is superior to the intravenously applied propofol anesthesia in off-pump coronary artery bypass grafting (OP-CABG) surgery as measured by following parameters: 1. hemodynamic parameters during and after the operation, 2. pulmonary gas exchange, need for mechanical ventilation and for ICU and intrahospital stay, 3. release of heart muscle injury markers in response to surgery and intraoperative ischaemia, 4. inflammatory response to the operation. We suspect that insufflation anesthesia with desflurane may be superior to intravenous anesthesia with propofol.

Detailed description

General anesthesia will be induced by intravenous dosis of fentanyl, vecuronium and etomidate and further maintained either by inhaled desflurane or propofol infusion, with concomitant empirically administered fentanyl doses and continuous infusion of vecuronium. After induction of anesthesia a Swan-Ganz catheter for continuous cardiac output, right ventricle end diastolic volume and blood saturation measurements will be introduced through the internal jugular vein. A transesophageal echocardiography probe will be placed additionally for the Tei-index measurement. Hemodynamic parameters will be recorded at the following time points: * before induction * after induction * during trachea intubation * before skin incision * 3 Min. after skin incision * after sternotomy * before heart positioning for graft placing * before finishing placing each distal anastomoses * 10, 20, 30, 40 min after placing the last anastomoses * 10 Min. after admission to ICU, 6, 12, 18 and 24 hours after surgery. * TEE measurements will be obtained after sternotomy and 20 Min after placing the last distal anastomoses. The results will be compared while using the parametric ANOVA test for normally distributed continuous data or the nonparametric Kruskal-Wallis/Wilcoxon-U test for categoric or inhomogeneous distributed continuous data.

Interventions

continuous intravenous infusion with a dose of 3-5 mg/kg/h

DRUGSuprane (desflurane), Baxter

a vapor concentration of 3-7 vol% is maintained with use of vaporizer and under control of arterial blood pressure, heart rate, and BIS index.

Sponsors

Medical University of Gdansk
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

* Patients with coronary artery disease qualified for CABG off-pump surgery * Elective surgery * Signed informed consent

Exclusion criteria

* Left ventricle ejection fraction \< 30% * Serum creatinine \> 2 mg/dL * Emergency surgery * Denied consent

Design outcomes

Primary

MeasureTime frame
Markers of heart muscle injury and inflammation will be compared: troponin I, creatinine phosphokinase and its heart specific fraction, C-reactive protein.within the first 2. days after surgery.

Secondary

MeasureTime frame
Evidence of clinically definite heart infarct confirmed by ECG and/or echocardiography, and heart muscle specific creatinine phosphokinase increase.To discharge from hospital (usually within 7 days)

Countries

Poland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 8, 2026